Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Fanelli

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 2021
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorderGernot Fugger, Lucie Bartova, Markus Dold, et al.
Journal of Affective Disorders|October 10, 2022
Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patternsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 20, 2025
Schizophrenia Genetics Modulates Clinical Depressive FeaturesAlessandro Serretti, Daniel Souery, Siegfried Kasper, et al.
CNS Spectrums|December 10, 2024
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challengesMauro Scala, Chiara Fabbri, Paolo Fusar-Poli, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countriesGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
Comprehensive Psychiatry|July 16, 2022
The Italian version of the Brief Assessment of Cognition in Affective Disorders: performance of patients with bipolar disorder and healthy controlsMaria Gloria Rossetti, Cinzia Perlini, Vera Abbiati, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 22, 2022
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideationGiuseppe Fanelli, Marcus Sokolowski, Danuta Wasserman, et al.
International Clinical Psychopharmacology|December 2, 2021
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohortsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
International Clinical Psychopharmacology|December 6, 2024
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorderMauro Scala, Daniel Sánchez-Reolid, Roberto Sánchez-Reolid, et al.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 2021
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorderGernot Fugger, Lucie Bartova, Markus Dold, et al.
Journal of Affective Disorders|October 10, 2022
Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patternsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 20, 2025
Schizophrenia Genetics Modulates Clinical Depressive FeaturesAlessandro Serretti, Daniel Souery, Siegfried Kasper, et al.
CNS Spectrums|December 10, 2024
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challengesMauro Scala, Chiara Fabbri, Paolo Fusar-Poli, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countriesGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
Comprehensive Psychiatry|July 16, 2022
The Italian version of the Brief Assessment of Cognition in Affective Disorders: performance of patients with bipolar disorder and healthy controlsMaria Gloria Rossetti, Cinzia Perlini, Vera Abbiati, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 22, 2022
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideationGiuseppe Fanelli, Marcus Sokolowski, Danuta Wasserman, et al.
International Clinical Psychopharmacology|December 2, 2021
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohortsVincenzo Oliva, Giuseppe Fanelli, Siegfried Kasper, et al.
International Clinical Psychopharmacology|December 6, 2024
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorderMauro Scala, Daniel Sánchez-Reolid, Roberto Sánchez-Reolid, et al.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
Pageof 9